The Trump administration’s aggressive corporate interventions—ranging from equity stakes in Intel to a veto-enabling 'golden share' in U. S. Steel—face imminent legislative scrutiny following a Democratic midterm resurgence.

Democratic lawmakers are expanding inquiries into potential state overreach and favoritism, recently targeting law firm Skadden Arps over Intel transaction details. For Wall Street, this political pivot introduces substantial regulatory uncertainty. Unprecedented state involvement previously reshaped governance at key industrial and tech targets, but upcoming congressional investigations could unravel public-private stock deals and executive veto structures.

Investors must now factor in heightened political and legal risk across state-involved corporations.